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Introduction
There are sparse data on SSI in oncology that is more
frequent than in general population. BCS is a clean sur-
gery performed in patients without co-morbidity. A pro-
spective survey we conducted in 2008 revealed a 4.1% SSI
incidence rate in 1686 BCS, resulting in new guidelines.
Objectives
We aimed to assess the SSI incidence rate in BCS and
to identify some risk factors.
Methods
Data collection concerned BCS, classified I or II in the
Altemeier classification, associated or not to immediate
breast reconstruction. The survey concerned at least 100
consecutive BCS performed in each of the 15 participating
comprehensive cancer centres in the first semester of
2011. Data collection was based on the French SSI report-
ing (age, ASA and NNISS scores, surgery and SSI dates,
involved strain). It was completed with some data specific
to cancer setting.
Results
Data were collected for 2883 BCS, including 2766 initial
BCS. The kind of surgery was available for 2731 initial
BCS: 1527 (56%) lumpectomies, 563 (21%) mastectomies,
143 (5%) and 170 (6%) immediate and secondary recon-
structions, respectively, 35 (1%) node dissections, 293
(11%) breast mammoplasty surgeries.
The SSI incidence rate (median onset delay: 16 days)
was 2.86%[CI95%: 2.27-3.55] (79 SSI) as compared to 4.1%
[CI95%: 3.20-5.15] in 2008, corresponding to a 30%
decrease. S. aureus was identified in 58 cases.
The multivariate analysis highlighted several factors
related to the risk of SSI onset. A 3-4 ASA score (vs ASA
1) was associated to an adjusted odds ratio (ORa) of 2.51
[1.21-5.18]). As compared to lumpectomies without node
dissection and prophylactic antibiotics, immediate recon-
structions were related to an ORa of 3.65[1.41- 9.42], node
dissection without prophylactic antibiotics and associated
or not to lumpectomy to an ORa of 4.58[2.13-9.87].
Hematoma and lymphocele punctures were respectively
related to an ORa of 3.19[1.33-7.66] and 2.98[1.84-4.83].
No relation was noted for prior chemo/radiotherapy and
for invasive preoperative procedures.
Conclusion
The identification of risk factors specific to cancer set-
ting argued to a particular attention, notably concerning
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